OR WAIT null SECS
June 15, 2023
Expansion expected to create additional production capacity, company says.
June 14, 2023
Changes to 3PL’s facility feature newly-converted controlled room temperature pallets.
June 13, 2023
CDMO’s new facility is expected to be operational by April 2025.
June 12, 2023
The accreditations—granted to the company’s sites in the US, LATAM, and Canada—are given for compliance with specific pharma manufacturer guidelines.
June 05, 2023
Decision is anticipated to boost operational efficiencies for the CDMO.
June 02, 2023
Company is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.
New PC column explores commercialization trends and how pharma can adjust to the new squeeze of market, regulatory, pricing, and gross-to-net pressures.
May 30, 2023
Company’s latest report reveals future plans, powered by efforts to divert more of its air shipments to sea.
May 24, 2023
New fill-finish plant strengthens nation’s reputation as an APAC biomedical hub.
May 19, 2023
Document reveals that 20 of 28 of participating Big Pharma manufacturers saw their DIO increase by an average of 5%, suggesting that large amounts of inventory do not necessarily offer protection from running low on medication.